|1.||Niikura, Kazuaki: 2 articles (09/2005 - 06/2004)|
|2.||Takano, Mikiko: 2 articles (09/2005 - 06/2004)|
|3.||Nakanishi, Masako: 1 article (07/2011)|
|4.||Yoneda, Toshiyuki: 1 article (07/2011)|
|5.||Nishisho, Toshihiko: 1 article (07/2011)|
|6.||Yasui, Natsuo: 1 article (07/2011)|
|7.||Morita, Yoshihiro: 1 article (07/2011)|
|8.||Sun-Wada, Ge-Hong: 1 article (07/2011)|
|9.||Wada, Yoh: 1 article (07/2011)|
|10.||Hata, Kenji: 1 article (07/2011)|
09/01/2005 - "Moreover, FR167356 was shown to restore BMD of ovariectomized rats caused by the inhibition of bone resorption. "
06/01/2004 - "As expected, FR167356 remarkably inhibited bone resorption in vitro. "
09/01/2005 - "A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application."
06/01/2004 - "Moreover, LDL metabolism in cells, which depends on acidification of lysosome, was blocked merely at higher concentration than bone resorption, suggesting that FR167356 inhibits V-ATPase of osteoclast ruffled border membrane still more selectively than lysosome at the cellular level. "
09/01/2005 - "Similarly, FR167356 inhibited bone resorption in vitro when stimulated by PTH, IL-1, and IL-6. "
|2.||Neoplasm Metastasis (Metastasis)
|3.||Hypercalcemia (Milk Alkali Syndrome)
|4.||Body Weight (Weight, Body)
|1.||Adenosine Triphosphatases (ATPase)
|2.||Vacuolar Proton-Translocating ATPases (V-Type ATPase)
|3.||Interleukin-6 (Interleukin 6)
|4.||Tretinoin (Retinoic Acid)
|5.||Interleukin-1 (Interleukin 1)